Asset Manager

Updated:

L'PAJ Ventures

Vincent J. Lopez runs L'PAJ Ventures alongside his health-tech company Parker Health, deploying capital into digital health from Washington, DC and Dallas.

L'PAJ Ventures logo

L'PAJ Ventures

L'PAJ Ventures was established by Vincent J. Lopez, who serves as its Managing Partner and Director. Lopez simultaneously founded and leads Parker Health as CEO, creating an unusual architecture where the investment firm and operating company share a founder but pursue independent mandates. The firm is headquartered in Washington, DC, with an additional presence in Dallas — a geographic footprint that spans federal health policy proximity and a growing hub for healthcare entrepreneurship. Lopez's own advisory roles, including a seat on the Dean's Council at the NYU School of Global Public Health and chairmanship of the Lopez Clinical Innovation Studio, reinforce the firm's orientation toward regulated healthcare markets. The firm practices generalist venture investing with a pronounced concentration in digital health. L'PAJ Ventures co-led Parker Health's $25 million Series A funding round alongside Bias Capital, with additional participation from CGT Capital Group. This deal illustrates the firm's preferred posture: backing health-tech companies at the growth stage where regulatory complexity meets product-market fit. The firm's investment in Parker Health — an enterprise software company modernizing health data infrastructure — signals a focus on companies that integrate with existing clinical and payment systems rather than pure consumer-health plays. While the full portfolio remains private, confirmed activities point to a strategy that blends internal company-building and externally sourced venture positions. L'PAJ's team size and total deployment are not publicly disclosed. The firm's structural reach extends beyond direct investing through Lopez's network memberships, which include the Royal Society of Medicine and The Sequoia Project — the latter a healthcare interoperability alliance that includes Parker Health itself. Lopez also serves as a Mentor Maker at the NASDAQ Entrepreneurial Center, a position that connects the firm to early-stage deal flow. A related family entity, the Lopez Foundation, operates separately as a philanthropic vehicle. No recent fund closes or vehicle launches have been publicly reported. L'PAJ Ventures is distinguished by its founder-level entanglement with Parker Health. Most emerging venture managers pitch a thesis; Lopez built the company he invests behind, then structured a separate entity to back others operating in the same regulated corridors. This makes the firm's investment decisions inseparable from its founder's operational knowledge of health-tech infrastructure — a dynamic closer to a family-backed operating fund than a conventional institutional venture firm.

General information

Firm type

Generalist

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Washington

Corporate office

Washington, DC, United States

Additional offices

Dallas, TX

Principals

Vincent J. Lopez

Managing Partner and Director

Sector focus

Digital HealthEnterprise Software

Frequently asked questions

Who runs investment decisions at L'PAJ Ventures?

Vincent J. Lopez serves as Managing Partner and Director and is the firm's named decision-maker. He concurrently operates as the founder and CEO of Parker Health, a portfolio company L'PAJ Ventures has backed. The firm has not publicly disclosed an investment committee structure beyond Lopez.

How is L'PAJ Ventures related to Parker Health?

Vincent J. Lopez founded both entities. L'PAJ Ventures co-led Parker Health's $25 million Series A, making the operating company both a portfolio holding and a shared founder vehicle. This dual relationship means the firm's investment acumen is directly informed by active company building within the same sector it targets as an investor.

What sectors does L'PAJ Ventures prioritize?

The firm pursues generalist venture investing with a clear center of gravity in digital health and enterprise software. The lead position in Parker Health, a company focused on modernizing health data infrastructure, anchors that concentration. Additional sector interests have not been publicly enumerated.

Does L'PAJ participate in fund commitments or only direct deals?

The firm's known transaction record consists of direct equity investments — specifically, a co-lead role in Parker Health's Series A. There is no public record of L'PAJ Ventures committing capital as a limited partner to third-party funds, though its small number of disclosed deals limits any definitive conclusion about its full mandate.

How does L'PAJ Ventures source its deals?

Vincent Lopez's operating and advisory network appears to serve as the primary sourcing engine. His roles with NYU's School of Global Public Health, The Sequoia Project, and the NASDAQ Entrepreneurial Center connect the firm to health-tech founders, policymakers, and early-stage companies. No outbound prospecting or intermediary relationship has been publicly detailed.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Washington Generalist profiles